2018 - Fellow, National Academy of Inventors
Pharmacology is intertwined with Dose–response relationship and Histamine in his research. His Histamine study typically links adjacent topics like Pharmacology. Many of his studies on Biochemistry apply to Urine as well. Many of his studies involve connections with topics such as Biochemistry and Urine. His research is interdisciplinary, bridging the disciplines of Pulmonary Eosinophilia and Asthma. His Pulmonary Eosinophilia study frequently draws parallels with other fields, such as Eosinophil. He applies his multidisciplinary studies on Eosinophil and Asthma in his research. Receptor is closely attributed to Antagonist in his work. His research on Internal medicine often connects related topics like ED50.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice.
Domenico Praticò;Rajendra K. Tangirala;Daniel J. Rader;Joshua Rokach.
Nature Medicine (1998)
Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo.
John A. Lawson;Joshua Rokach;Garret A. FitzGerald.
Journal of Biological Chemistry (1999)
Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo
Domenico Pratico;Virginia M.-Y. Lee;John Q. Trojanowski;Joshua Rokach.
The FASEB Journal (1998)
Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
Guillaume Monneret;Sylvie Gravel;Michael Diamond;Joshua Rokach.
Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
Domenico Praticò;Christopher M. Clark;Virginia M.‐Y. Lee;John Q. Trojanowski.
Annals of Neurology (2000)
Effects of vitamin E on lipid peroxidation in healthy persons.
Emma A. Meagher;Orla P. Barry;John A. Lawson;Joshua Rokach.
Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist.
T. R. Jones;R. Zamboni;M. Belley;E. Champion.
Canadian Journal of Physiology and Pharmacology (1989)
Increased Formation of Distinct F2 Isoprostanes in Hypercholesterolemia
Muredach P. Reilly;Domenico Praticò;Norman Delanty;Giovanni DiMinno.
ALCOHOL-INDUCED GENERATION OF LIPID PEROXIDATION PRODUCTS IN HUMANS
Emma A. Meagher;Orla P. Barry;Anne Burke;Michael R. Lucey.
Journal of Clinical Investigation (1999)
Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans
Muredach P. Reilly;Norman Delanty;Louis Roy;Joshua Rokach.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: